Inhibition of neutrophil elastase-induced goblet cell metaplasia by tiotropium in mice.
Airway occlusion by mucus in chronic obstructive disease (COPD) is associated with a poor prognosis. We hypothesised that tiotropium has the ability to inhibit neutrophil elastase (NE)-induced goblet cell metaplasia in mice and mucin production in vitro. On days 1, 4, and 7, tiotropium or vehicle was administered to C57BL/6 mice by inhalation and they were allowed to intranasally aspirate human NE. Bronchoalveolar lavage fluid (BALF) and lung sections were analysed on days 8, 11 and 14. The effect of late administration of tiotropium on the goblet cell metaplasia by NE aspiration was also assessed. NE-induced MUC5AC production by NCI-H292 cells was measured with ELISA. Repeated NE aspiration induced marked goblet cell metaplasia. The grading of goblet cell metaplasia, neutrophil count and eosinophil count in BALF, keratinocyte-derived chemokine level and leukotriene B(4) level in BALF, and M(3) receptor expression by immunohistochemistry, were lower in the tiotropium group than in the vehicle group. Late administration of tiotropium inhibited the established goblet cell metaplasia. Tiotropium inhibited NE-induced MUC5AC production. Tiotropium inhibited NE-induced goblet cell metaplasia and mucin production, probably mediated by suppression of inflammation and a direct action on epithelial cells. This result suggests that tiotropium may be useful for the treatment of mucus overproduction in COPD.
Arai
N
N
First Dept of Medicine, Tokyo Women's Medical University School of Medicine, Tokyo, Japan.
Kondo
M
M
Izumo
T
T
Tamaoki
J
J
Nagai
A
A
D000280:Administration, Inhalation; D000818:Animals; D001992:Bronchoalveolar Lavage Fluid / Q000737:chemistry / Q000166:cytology; D002478:Cells, Cultured; D020397:Goblet Cells / Q000378:metabolism* / Q000473:pathology*; D006801:Humans; D019272:Leukocyte Elastase / Q000633:toxicity*; D008297:Male; D008679:Metaplasia / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D055271:Mucin 5AC / Q000187:drug effects* / Q000378:metabolism*; D020545:Respiratory Mucosa / Q000187:drug effects* / Q000378:metabolism*; D012602:Scopolamine Derivatives / Q000008:administration & dosage / Q000494:pharmacology*; D000069447:Tiotropium Bromide
D055271:Mucin 5AC; D012602:Scopolamine Derivatives; D019272:Leukocyte Elastase; D000069447:Tiotropium Bromide